« Back
Home /
Devimistat (CPI-613)

Devimistat (CPI-613)

Item no.	S2776-10mM
Manufacturer	Selleckchem
CASRN	95809-78-2
Amount	10 mM/1 mL
Quantity options	1 g 10 g 10 mM/1 mL 5 mg 50 mg 5 g
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	95809-78-2'
Similar products	95809-78-2
Available
Storage Conditions	2 years -80 in solvent
Information	Devimistat (CPI-613), a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase in NCI-H460 cell line, disrupts tumor cell mitochondrial metabolism. CPI-613 induces apoptosis in pancreatic cancer cells. Phase 2.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S2776-10mM-datasheet.pdf

S2776-10mM-safety-datasheet.pdf